home / stock / bbio / bbio articles

BBIO Articles, BridgeBio Pharma Inc.

Stock Information
Company Name: BridgeBio Pharma Inc.
Stock Symbol: BBIO
Market: NYSE
Website: bridgebio.com
Menu
BBIO BBIO Quote BBIO Short BBIO News BBIO Articles BBIO Message Board
Get BBIO Alerts

News, Short Squeeze, Breakout and More Instantly...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma, Inc. - BBIO | Benzinga

NEW YORK, June 30, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of BridgeBio Pharma, Inc. ("BridgeBio" ...
ResMed, Coinbase Global, Nvidia And Other Big Stocks Moving Lower On Monday | Benzinga

U.S. stocks were mixed, with the Dow Jones index gaining around 300 points on Monday. Shares of ResMed Inc. (NYSE:RMD) fell sharply during Monday&#...

BridgeBio Pharma to Participate in the 45th Annual Goldman Sachs Global Healthcare Conference | Benzinga

PALO ALTO, Calif., June 06, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ:BBIO) ("BridgeBio" or the "Company"), a commercial-stage bio...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma, Inc. - BBIO | Benzinga

NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of BridgeBio Pharma, Inc. ("BridgeBio" ...
BridgeBio Pharma Shares One Year Data From Dwarfism Candidate | Benzinga

Tuesday, BridgeBio Pharma Inc (NASDAQ:BBIO) announced sustained results from the PROPEL 2 Phase 2 trial of the investigational therapy infigratinib...

Why BridgeBio Pharma Stock Is Trading Lower Tuesday | Benzinga

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is moving lower Tuesday after the company announced results from its Phase 2 trial of infigratinib in childre...

BridgeBio to Host Call on Month 12 and 18 Phase 2 Cohort 5 Results of Oral Infigratinib in Achondroplasia on June 4, 2024 | Benzinga

PALO ALTO, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ:BBIO) (BridgeBio), a commercial-stage biopharmaceutical comp...
BridgeBio Pharma to Participate in the Bank of America Merrill Lynch Global Healthcare Conference 2024 | Benzinga

PALO ALTO, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ:BBIO) ("BridgeBio" or the "Company"), a commercial-stage biop...

BridgeBio Pharma Announces Proposed Public Offering of Common Stock | Benzinga

PALO ALTO, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ:BBIO) ("BridgeBio"), a commercial-stage biopharmaceutical c...

What's Going On With BridgeBio Pharma Stock On Monday? | Benzinga

Monday, BridgeBio Pharma Inc (NASDAQ:BBIO) and Bayer AG (OTC:BAYRY) (OTC:BAYZF) announced a partnership wherein BridgeBio grant...
Next 10